CheckMate 914: Nivo/Ipi in RCC
CheckMate 914 (Part A): Adjuvant Nivolumab + Ipilimumab vs Placebo in Localized RCC at High Risk of Relapse Following Nephrectomy

Released: September 19, 2022

Expiration: September 18, 2023

Activity

Progress
1
Course Completed